Cargando...

The GIST of Targeted Therapy for Malignant Melanoma

The high response rates to the tyrosine kinase inhibitor imatinib in KIT-mutated gastrointestinal stromal tumors (GIST) has led to a paradigm shift in cancer treatment. In a parallel fashion, the field of melanoma is shifting with the utilization of targeted therapy to treat BRAF-mutated melanoma. W...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bello, Danielle M., DeMatteo, Ronald P., Ariyan, Charlotte E.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4041068/
https://ncbi.nlm.nih.gov/pubmed/24531699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3373-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!